Citation: Tl. Wallace et al., Alterations in diurnal and nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of methamphetamine or 3,4-methylenedioxymethamphetamine, PSYCHOPHAR, 153(3), 2001, pp. 321-326
Citation: M. Shankaran et al., Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT, SYNAPSE, 40(1), 2001, pp. 55-64
Citation: Tl. Wallace et al., Neurotoxic regimen of methamphetamine produces evidence of behavioral sensitization in the rat, SYNAPSE, 39(1), 2001, pp. 1-7
Authors:
Nixdorf, WL
Burrows, KB
Gudelsky, GA
Yamamoto, BK
Citation: Wl. Nixdorf et al., Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate, J NEUROCHEM, 77(2), 2001, pp. 647-654
Citation: M. Shankaran et Ga. Gudelsky, A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration, PSYCHOPHAR, 147(1), 1999, pp. 66-72
Citation: Ga. Gudelsky, Biphasic effect of sigma receptor ligands on the extracellular concentration of dopamine in the striatum of the rat, J NEURAL TR, 106(9-10), 1999, pp. 849-856
Citation: Tl. Wallace et al., Methamphetamine-induced neurotoxicity alters locomotor activity, stereotypic behavior, and stimulated dopamine release in the rat, J NEUROSC, 19(20), 1999, pp. 9141-9148
Citation: M. Shankaran et al., Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum, J NEUROCHEM, 72(6), 1999, pp. 2516-2522
Citation: H. Shankaran et al., Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine, EUR J PHARM, 385(2-3), 1999, pp. 103-110